20/20 GeneSystems, Inc. — Form D/A

20/20 GeneSystems, Inc. of Gaithersburg, MD, a company, filed a Form D amendment with the SEC on 2016-02-19. The offering totals $4.0M, of which $2.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (18)

NameRoleLocation
Dean HautamakiDirectorRockville, MD
Joel KanterDirectorVienna, VA
Vladimir KnezevicDirectorRockville, MD
Caroline PopperDirectorDelray Beach, FL
Donald WallachDirectorRockville, MD
Joel KanterExecutive OfficerVienna, VA
Jonathan CohenDirectorJericho, NY
Jonathan CohenExecutive OfficerJericho, NY
Prasanth G ReddyDirectorGaithersburg, MD
John G ComptonDirectorGaithersburg, MD
Wei G LuDirectorGaithersburg, MD
Anne ShiflettExecutive OfficerGaithersburg, MD
Jiminy ZhouExecutive OfficerGaithersburg, MD
Michael A RossDirectorGaithersburg, MD
John W RollinsDirectorHuntington Beach, CA
Michael HertzbergDirectorRockville, MD
Larry ShulmanDirectorRockville, MD
RICHARD M COHENDirectorWest Palm Beach, FL

Other filings by this issuer (4)

FiledFormOfferingSold
2025-02-26D$3.0M$70K
2016-02-04D$3.0M$2.0M
2015-10-30D/A$4.0M$2.2M
2015-09-22D$4.0M$2.0M

More